Clinical analysis of 137 cases of ultrasound-guided positioning for resection of non-palpable breast masses

Objective: The aim of this study was to evaluate the clinical value of ultrasound-guided resection of non-palpable breast masses. Materials and Methods: One hundred thirty-seven cases of non palpable breast mass patients who underwent surgical treatment from June 2007 to June 2012 were enrolled in this study. All patients were found with breast masses in mammography or ultrasound, and underwent preoperative routine ultrasound-guided wire positioning. Results: One hundred fifty-eight lesions underwent ultrasound positioning accurate resection, of which 34 cases (21.5%) were malignant, including 26 cases (16.5%) of intraductal carcinoma, four cases (2.5%) of infiltrating ductal carcinoma, and three cases (1.9%) of invasive lobular carcinoma. Thirteen patients underwent modified radical mastectomy, and 21 cases (61.8%) underwent breast conservation operation. All patients were followed up for six to 53 months, only one patient had pulmonary metastasis after two years, and there was no local recurrence. Conclusion: Resection of non-palpable breast masses with preoperative ultrasound-guided positioning has advantages of accurate positioning and simple operation and is of great significance for early diagnosis and treatment of breast cancer.

Breast disease; Ultrasonography; Non-palpable mass; Positioning.

[1] Franceschi D., Crowe J., Zollinger R., Duchesneau R., Shenk R., Stefanek G., et al.: “Breast biopsy for calcifications in nonpalpable breast lesions. A prospective study”. Arch. Surg., 1990, 125, 170.

[2] Papatestas A.E., Hermann D., Hermann G., Tsevdos C., Lesnick G.: “Surgery for nonpalpable breast lesions”. Arch. Surg., 1990, 125, 399.

[3] Johnson K.S., Baker J.A., Lee S.S., Soo M.S.: “Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes”. Acad. Radiol., 2013, 20, 569.

[4] Fontein D.B., van de Water W., Mieog J.S., Liefers G.J., van de Velde C.J.: “Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy-recommendations for clinical guidance”. Eur. J. Surg. Oncol., 2013, 39, 417.

[5] Davis P.S., Wechsler R.J., Feig S.A., March D.E.: “Migration of breast biopsy localization wire”. AJR Am. J. Roentgenol., 1988, 150, 787.

[6] Bronstein A.D., Kilcoyne R.F., Moe RE.: “Compilcations of needle localization of foreign bodies and nonpalpable breast lesions”. Arch. Surg., 1988, 123, 775.

[7] Owen A.W., Kumar E.N.: “Migration of localizing wires used in guided biopsy of the breast”. Clin. Radiol., 1991, 43, 251.

[8] Eby P.R., Calhoun K.E., Kurland B.F., Demartini W.B., Gutierrez R.L., Peacock S., et al.: “Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips”. Acad. Radiol., 2010, 17, 340.

[9] Dua S.M., Gray R.J., Keshtgar M.: “Strategies for localisation of impalpable breast lesions”. Breast, 2011, 20, 246.

[10] Sung J.S., King V., Thornton C.M., Brooks J.D., Fry C.W., El-Tamer M., et al.: “Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy”. Eur. J. Radiol., 2013, 82, 1453.

[11] O'.Flynn E.A., Wilson A.R., Michell M.J.: “Image-guided breast biopsy: state-of-the-art”. Clin. Radiol., 2010, 65, 259.

[12] Rogers L.W.: “Breast biopsy: A pathologist’s perspective on biopsy acquisition techniques and devices with mammographic-pathologic correlation”. Semin. Breast Dis., 2005, 8, 127.

[13] Krekel N.M., Zonderhuis B.M., Schreurs H.W., Cardozo A.M., Rijna H., van der Veen H., et al.: “Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound- guided surgery to traditional palpation-guided surgery (COBALT trial)”. MBC Surgery, 2011, 11, 8.

[14] Jakub J.W., Gray R.J., Degnim A.C., Boughey J.C., Gardner M., Cox C.E.: “Current status of radioactive seed for localization of non palpable breast lesions”. Am. J. Surg., 2010, 199, 522.

[15] Soot L., Weerasinghe R., Wang L., Nelson HD.: “Rates and indications for surgical breast biopsies in a community-based health system”. Am. J. Surg., 2014, 207, 499.

[16] Naim F., Ballinger R., Rombach I., Hadjiminas D.J., Al-Mufti R., Hogben R.K. et al.: “Patient attitudes towards undergoing additional breast biopsy for research”. Breast, 2013, 22, 850.

[17] Yagata H., Yamauchi H., Tsugawa K., Hayashi N., Yoshida A., Kajiura Y., et al.: “Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer”. Clin. Breast Cancer, 2013, 13, 471.

[18] Sanuki N., Takeda A., Amemiya A., Ofuchi T., Ono M., Ogata H., et al.: “Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy”? Clin. Breast Cancer, 2013, 13, 69.

[19] Wang K., Ye Y., Sun G., Xu Z.: “The Mammotome biopsy system is an effective treatment strategy for breast abscess”. Am. J. Surg., 2013, 205, 35.

[20] Miller L.S., Shelby R.A., Balmadrid M.H., Yoon S., Baker J.A., Wildermann L. et al.: “Patient Anxiety Before and Immediately After Imaging-Guided Breast Biopsy Procedures: Impact of Radiologist- Patient Communication”. J. Am. Coll. Radiol., 2013, 10, 423.